Anorexia NervosaQOLAN-DKNCT03230435
Health Related Quality of Life for Patients With Anorexia Nervosa in Denmark.
An observational study of Anorexia Nervosa and Health-Related Quality Of Life, run by René Klinkby Støving at 1 site in Denmark.
Trial summary
Eating disorders (ED) comprise a multitude of symptoms involving a disturbed body image and a preoccupation with food or bodyweight. EDs are often difficult to treat, in part due to the lack of motivation for improvement. Read more about this study
- Who is it for?
- Ages 13 to 40 yearsHealthy volunteers can take part
- Conditions the study is for
- Anorexia Nervosa, Health-Related Quality Of Life
- What is being tested?
- Treatment settings as usual.
- How many people
- 496 participants
- Where
- 1 siteDenmark
- Study dates
- 1 Mar 2017to 1 Jan 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 13 to 40 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Study population: PATIENTS will be recruited through specialized centres in Denmark and through contact to Patient Association's network. CONTROLS will be identified through public call for proposals. The proposals will be posted at institutions of further education and public schools in Odense with students in the appropriate age range.
Who may be able to join
- 1. Patients fulfilling Diagnostic and Statistical Manual of Mental Disorders, version 5 (DSM-5) criteria for anorexia nervosa.
Who cannot join
- Patients and controls who are unable to complete a Danish language questionnaire.
- Controls: Any medication, except vitamins or oral contraceptives.
Trial locations and contacts
1 site in 1 country.
Denmark1 site
Department of Endocrinology, Center for Eating Disorders, Odense UH
Odense C, 5000
About this study
Eating disorders (ED) comprise a multitude of symptoms involving a disturbed body image and a preoccupation with food or bodyweight. EDs are often difficult to treat, in part due to the lack of motivation for improvement. Anorexia nervosa (AN) has the highest mortality rate of any psychiatric disease, and less than half of patients will recover from the disease. Studies have found that patients suffering from AN have impaired health-related quality of life (HRQoL) compared to the general population. It has also been suggested that despite improvement in clinical parameters, patients report deterioration in HRQoL, which is in line with a study finding low agreement between patient perceived outcome and clinician assessed characteristics. To evaluate the patients' perception of their disease, it is important to develop reliable and valid assessment tools. Previously generic questionnaires have been used to assess HRQoL in Danish ED patients, as no disease-specific questionnaires have been developed. Translating and validating a disease-specific questionnaire would provide a useful tool in assessing current treatment and in developing new treatment options. This study aimed to develop a Danish version of an internationally disease-specific HRQoL questionnaire. Furthermore, HRQoL is assessed in patients who have gone through shorter or longer treatment.
Read the detailed description
INTRODUCTION Anorexia nervosa (AN) is an eating disorder of unknown etiology. The evidence base for treatment is still very limited considering the extent to which this disorder erodes lives and still carries the highest fatality rate of any psychiatric disease as well as any other chronic disease in adolescence.
There is no consensus on appropriate effect goals in AN. Assessment of biomedical parameters alone is not sufficient, why evaluation tools that consider the patient's own perception of their health and well-being are essential. However, patients with AN characteristically have a different opinion of their needs to that of the health professionals, which can lead to differences in treatment goals, ambivalence towards treatment, and immense compliance difficulties.
Health-related quality of life (HRQOL) can be defined as the overall effect of a medical condition and/or its consequent therapy upon a patient. HRQOL is subjective and multidimensional, encompassing physical and occupational function, psychological state, social interaction and somatic sensation. Discrepancy between one's current level of function and one's ideals or expectations can result in lower self-rated HRQOL, while cognitive flexibility is believed to contribute to good HRQOL. Patients with AN typically have unrealistically high expectations of themselves, are often rigid and usually do not consider weight gain to be a necessity for a positive outcome. Therefore, treatment may potentially lead to further reduction of HRQOL (for example due to coerced hospitalization), despite significant positive improvements in biomedical parameters.
In a recently published meta-analysis examining the HRQOL of patients with eating disorders, several methodological challenges were identified such as variations in study design, diagnostic criteria and health outcome measurement. It is essential that HRQOL measures are valid and reliable for the patient group in question. These measures can be either generic (applicable to all patient groups) or disease-specific (designed to detect HRQOL changes specific to a disease).
Only a few disease-specific HRQOL measures for AN have been developed. The Eating Disorder Quality of Life (EDQLS) questionnaire was published by a Canadian research group and consists of 40 items on selected topics including relationships with family and others, physical and psychological health and eating. Subsequent studies have shown that the EDQLS demonstrates excellent psychometric properties in terms of validity, reliability and responsiveness to change.
OBJECTIVES
- To validate a Danish version of the Eating Disorder Quality of Life questionnaire in two age ranges, 13-17 years and +18 years in patients with AN.
- To assess age-specific HRQoL in patients with AN in different treatment settings.
DESIGN Preparatory study: Testing and adaptation of the Danish version of the EDQLS for use by 13-17 year olds with anorexia nervosa.
Study 1: Concurrent validity and internal consistency. EDQLS, ED symptomatology, distress, social function and generic HRQOL assessed in different clinical samples of AN patients aged 13-17 \& +18 years and in a sample of age-matched healthy controls within a normal weight range.
Study 2: Test-retest reliability. EDQLS completed twice with a 2-4-week interval in a sample of weight- and treatment-stable outpatients and controls aged 13-17 \& +18 years.
Study 3: Sensitivity to change. EDQLS applied three times over a 4-6-week interval in a sample of AN inpatients aged 13-17 \& +18 years.
Study 4: Patients outside the established treatment. EDQLS, ED symptomatology, distress, social function and generic HRQoL score among members and followers with BMI<18 recruited from the official website for the national patient organizations.
METHODS
TRANSLATION Prior to this study, the initial translations of the EDQLS was carried out using the method recommended by WHO World Mental Health Initiative Translation Guidelines. After permission from the Canadian authors, an expert panel of bilingual staff from an ED outpatient clinic worked on the translation from English to Danish, aiming for conceptual equivalence between the versions (i.e. similar relevance and meaning in the two languages/cultures). After panel discussions to create a consensus version the Danish draft questionnaire was completed individually by 18 adult women with AN, who in subsequent qualitative interviews commented on their understanding of the items and any difficulties they had with the wording. The linguistic comments and suggestions from the patients were used to further improve the translation, which was then approved by the expert panel. This draft was back-translated and the back-translation was reviewed by the Canadian authors of the scale. After the refinement of a single word, it was accepted as the official Danish EDQLS translation. Both the Danish version and the original EDQLS are licensed.
In the present study, the original EDQLS will be tested and adjusted as necessary for use patients aged 13-17 years. This will be done by repeating the qualitative interviews with six adolescents AN patients (13-17 years) to investigate whether the questionnaire should be linguistically modified for this age group. Any modifications will be discussed with the Canadian developers of EDQLS.
MEASURES Screening questionnaire: Patients will be asked to fill out a questionnaire regarding current weight, height and information regarding current medication.
Disease-specific quality of life (EDQLS). WHO-5 Well-being Index (WHO-5). Generic health related quality of life: Short Form-36 (SF-36). Eating disorder symptomatology: Eating Disorder Inventory-3. Depression: The Beck Depression Inventory II (BDI-II). Impairment in functioning: Work and Social Adjustment Scale (WSAS). Total item burden: Total amount of measures is 201 items. Estimated time for administration is about two hours. The questionnaires are stored in RedCap, automatically uploading the answers as the patients fill them out.
DATA ANALYSES AND STATISTICS
POWER CALCULATIONS The sample size is based on the validation work of the original language version in Canada. A high response rate of at least 80% is expected because there is a high participatory interest in the subject and purpose of the study, and because the participants receive a small fee.
MULTIVARIATE ANALYSES Description of the subsamples is presented as means and standard deviations and frequencies. Inter-item correlations and confirmatory factor analyses are performed on the full sample across age-groups and health status and in sub-populations. Pearson correlations are produced for the included symptom and HRQOL scores.
ETHICAL CONSIDERATIONS According to Danish legislation, surveys are exempt from ethical board review. However, a formal enquiry was made and the ethical board determined that the project was approved without further application to the ethical committee. Participants will be informed that study participation is voluntary, and will have no effect on their treatment and management. There are no risks associated with participating in the study.
All questionnaires and tests used in the study are validated, recommended and widely distributed clinically for diagnosing in psychiatry.
To facilitate a high proportion of completion, all participants (patients and controls) who complete the test are honored with Danish kroner (DDK) 150.
ANONYMITY The project is approved by the Data Protection Agency, File no. 17/3218. The data will be stored in a data sheet, REDCap.
FINANCE The study is a 100 % non-commercial study. The Jascha Fund has supported the post doc salary for 18 months. There will be applied for licenses, participation fees, and operating expenses.
DISSEMINATION AND TENTATIVE PUBLICATIONS
The study findings, both positive and negative results, will be disseminated through communication at congresses and written scientific publications. Publications will be made according to the Vancouver criteria with the tentative titles:
- Health-related quality of life in anorexia nervosa: Validation of a Danish language version in young and adult patients.
- In-patients treatment of anorexia nervosa: Does it improve health related quality of life?
- Patients with anorexia nervosa, not seeking established treatment: specific health related quality of life.
- Gender differences in health-related quality of life in patients with anorexia nervosa.
- Conditions
- Anorexia Nervosa, Health-Related Quality Of Life
- Being tested
- Treatment settings as usual.
- Keywords
- anorexia nervosa, health-related quality of life
- Medical subject headings
- Anorexia Nervosa
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Treatment settings as usual.Other
Treatment according to guidelines and the local instructions (psychotherapy and dietary guidance).
| Study group | Role | What they receive |
|---|---|---|
| Anorexia nervosa | Treatment settings as usual. Receives: Other: Treatment settings as usual. | |
| Healthy controls | No interventions. |
What is being measured
The primary outcome is the main question the study is designed to answer.
EDQLS
Disease specific health related quality of life
Measured: through a hospitalization, an average of 5 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jul 2017
- Study start1 Mar 2017
- Primary completion1 Feb 2024
- Study completion1 Jan 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Anorexia NervosaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 496 participants (estimated)
Sponsor and investigators
- Lead sponsor
- René Klinkby Støving
- Sponsor type
- University, hospital or other
- Collaborators
- Region of Southern Denmark, University of Southern Denmark
- Responsible party
- Sponsor-investigator, René Klinkby Støving, Odense University Hospital
- Investigators
- René K Støving, PhD, Principal investigator, Center for Eating Disorders, Odense University Hospital, & Psychiatric survived in Southern Denmark
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03230435
- Sponsor's protocol ID
- QOLAN-DK 10226757
- Acronym
- QOLAN-DK
- Status last verified
- Feb 2024
- First submitted
- 20 Jul 2017
- Last updated
- 6 Feb 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Data will be stored at Odense patient Data Explorative Network (OPEN).
Publications
Winkler LA, Frolich JS, Gudex C, Horder K, Bilenberg N, Stoving RK. Patient- and clinician- reported outcome in eating disorders. Psychiatry Res. 2017 Jan;247:230-235. doi: 10.1016/j.psychres.2016.11.047. Epub 2016 Nov 30.
PubMed 27923148Winkler LA, Christiansen E, Lichtenstein MB, Hansen NB, Bilenberg N, Stoving RK. Quality of life in eating disorders: a meta-analysis. Psychiatry Res. 2014 Sep 30;219(1):1-9. doi: 10.1016/j.psychres.2014.05.002. Epub 2014 May 14.
PubMed 24857566Winkler LA, Bilenberg N, Horder K, Stoving RK. Does specialization of treatment influence mortality in eating disorders?--A comparison of two retrospective cohorts. Psychiatry Res. 2015 Dec 15;230(2):165-71. doi: 10.1016/j.psychres.2015.08.032. Epub 2015 Aug 28.
PubMed 26391650Adair CE, Marcoux GC, Cram BS, Ewashen CJ, Chafe J, Cassin SE, Pinzon J, Gusella JL, Geller J, Scattolon Y, Fergusson P, Styles L, Brown KE. Development and multi-site validation of a new condition-specific quality of life measure for eating disorders. Health Qual Life Outcomes. 2007 Apr 30;5:23. doi: 10.1186/1477-7525-5-23.
PubMed 17470290Adair CE, Marcoux GC, Bischoff TF, Cram BS, Ewashen CJ, Pinzon J, Gusella JL, Geller J, Scattolon Y, Fergusson P, Styles L, Brown KE. Responsiveness of the Eating Disorders Quality of Life Scale (EDQLS) in a longitudinal multi-site sample. Health Qual Life Outcomes. 2010 Aug 11;8:83. doi: 10.1186/1477-7525-8-83.
PubMed 20701776Winkler LA, Hemmingsen SD, Gudex C, Blegvad AC, Stoving RK, Arnfred SMH. A Danish translation of the eating disorder quality of life scale (EDQLS). J Eat Disord. 2019 May 1;7:11. doi: 10.1186/s40337-019-0241-7. eCollection 2019.
PubMed 31069077
Study at a glance
From the registry record, last updated by the sponsor on 6 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Health Related Quality of Life for Patients With Anorexia Nervosa in Denmark.
- ClinicalTrials.gov ID
- NCT03230435
- Acronym / sponsor ID
- QOLAN-DK / QOLAN-DK 10226757
- Conditions
- Anorexia Nervosa, Health-Related Quality Of Life
- Keywords
- anorexia nervosa, health-related quality of life
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 496 participants (estimated)
- Lead sponsor
- René Klinkby StøvingUniversity, hospital or other
- Collaborators
- Region of Southern Denmark, University of Southern Denmark
- Study start
- 1 Mar 2017 (actual)
- Primary completion
- 1 Feb 2024 (actual)
- Study completion
- 1 Jan 2025 (estimated)
- First posted
- 26 Jul 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Eating disorders (ED) comprise a multitude of symptoms involving a disturbed body image and a preoccupation with food or bodyweight. EDs are often difficult to treat, in part due to the lack of motivation for improvement. Anorexia nervosa (AN) has the highest mortality rate of any psychiatric disease, and less than half of patients will recover from the disease. Studies have found that patients suffering from AN have impaired health-related quality of life (HRQoL) compared to the general population. It has also been suggested that despite improvement in clinical parameters, patients report deterioration in HRQoL, which is in line with a study finding low agreement between patient perceived outcome and clinician assessed characteristics. To evaluate the patients' perception of their disease, it is important to develop reliable and valid assessment tools. Previously generic questionnaires have been used to assess HRQoL in Danish ED patients, as no disease-specific questionnaires have been developed. Translating and validating a disease-specific questionnaire would provide a useful tool in assessing current treatment and in developing new treatment options. This study aimed to develop a Danish version of an internationally disease-specific HRQoL questionnaire. Furthermore, HRQoL is assessed in patients who have gone through shorter or longer treatment.
Detailed description
INTRODUCTION Anorexia nervosa (AN) is an eating disorder of unknown etiology. The evidence base for treatment is still very limited considering the extent to which this disorder erodes lives and still carries the highest fatality rate of any psychiatric disease as well as any other chronic disease in adolescence.
There is no consensus on appropriate effect goals in AN. Assessment of biomedical parameters alone is not sufficient, why evaluation tools that consider the patient's own perception of their health and well-being are essential. However, patients with AN characteristically have a different opinion of their needs to that of the health professionals, which can lead to differences in treatment goals, ambivalence towards treatment, and immense compliance difficulties.
Health-related quality of life (HRQOL) can be defined as the overall effect of a medical condition and/or its consequent therapy upon a patient. HRQOL is subjective and multidimensional, encompassing physical and occupational function, psychological state, social interaction and somatic sensation. Discrepancy between one's current level of function and one's ideals or expectations can result in lower self-rated HRQOL, while cognitive flexibility is believed to contribute to good HRQOL. Patients with AN typically have unrealistically high expectations of themselves, are often rigid and usually do not consider weight gain to be a necessity for a positive outcome. Therefore, treatment may potentially lead to further reduction of HRQOL (for example due to coerced hospitalization), despite significant positive improvements in biomedical parameters.
In a recently published meta-analysis examining the HRQOL of patients with eating disorders, several methodological challenges were identified such as variations in study design, diagnostic criteria and health outcome measurement. It is essential that HRQOL measures are valid and reliable for the patient group in question. These measures can be either generic (applicable to all patient groups) or disease-specific (designed to detect HRQOL changes specific to a disease).
Only a few disease-specific HRQOL measures for AN have been developed. The Eating Disorder Quality of Life (EDQLS) questionnaire was published by a Canadian research group and consists of 40 items on selected topics including relationships with family and others, physical and psychological health and eating. Subsequent studies have shown that the EDQLS demonstrates excellent psychometric properties in terms of validity, reliability and responsiveness to change.
OBJECTIVES
- To validate a Danish version of the Eating Disorder Quality of Life questionnaire in two age ranges, 13-17 years and +18 years in patients with AN.
- To assess age-specific HRQoL in patients with AN in different treatment settings.
DESIGN Preparatory study: Testing and adaptation of the Danish version of the EDQLS for use by 13-17 year olds with anorexia nervosa.
Study 1: Concurrent validity and internal consistency. EDQLS, ED symptomatology, distress, social function and generic HRQOL assessed in different clinical samples of AN patients aged 13-17 \& +18 years and in a sample of age-matched healthy controls within a normal weight range.
Study 2: Test-retest reliability. EDQLS completed twice with a 2-4-week interval in a sample of weight- and treatment-stable outpatients and controls aged 13-17 \& +18 years.
Study 3: Sensitivity to change. EDQLS applied three times over a 4-6-week interval in a sample of AN inpatients aged 13-17 \& +18 years.
Study 4: Patients outside the established treatment. EDQLS, ED symptomatology, distress, social function and generic HRQoL score among members and followers with BMI<18 recruited from the official website for the national patient organizations.
METHODS
TRANSLATION Prior to this study, the initial translations of the EDQLS was carried out using the method recommended by WHO World Mental Health Initiative Translation Guidelines. After permission from the Canadian authors, an expert panel of bilingual staff from an ED outpatient clinic worked on the translation from English to Danish, aiming for conceptual equivalence between the versions (i.e. similar relevance and meaning in the two languages/cultures). After panel discussions to create a consensus version the Danish draft questionnaire was completed individually by 18 adult women with AN, who in subsequent qualitative interviews commented on their understanding of the items and any difficulties they had with the wording. The linguistic comments and suggestions from the patients were used to further improve the translation, which was then approved by the expert panel. This draft was back-translated and the back-translation was reviewed by the Canadian authors of the scale. After the refinement of a single word, it was accepted as the official Danish EDQLS translation. Both the Danish version and the original EDQLS are licensed.
In the present study, the original EDQLS will be tested and adjusted as necessary for use patients aged 13-17 years. This will be done by repeating the qualitative interviews with six adolescents AN patients (13-17 years) to investigate whether the questionnaire should be linguistically modified for this age group. Any modifications will be discussed with the Canadian developers of EDQLS.
MEASURES Screening questionnaire: Patients will be asked to fill out a questionnaire regarding current weight, height and information regarding current medication.
Disease-specific quality of life (EDQLS). WHO-5 Well-being Index (WHO-5). Generic health related quality of life: Short Form-36 (SF-36). Eating disorder symptomatology: Eating Disorder Inventory-3. Depression: The Beck Depression Inventory II (BDI-II). Impairment in functioning: Work and Social Adjustment Scale (WSAS). Total item burden: Total amount of measures is 201 items. Estimated time for administration is about two hours. The questionnaires are stored in RedCap, automatically uploading the answers as the patients fill them out.
DATA ANALYSES AND STATISTICS
POWER CALCULATIONS The sample size is based on the validation work of the original language version in Canada. A high response rate of at least 80% is expected because there is a high participatory interest in the subject and purpose of the study, and because the participants receive a small fee.
MULTIVARIATE ANALYSES Description of the subsamples is presented as means and standard deviations and frequencies. Inter-item correlations and confirmatory factor analyses are performed on the full sample across age-groups and health status and in sub-populations. Pearson correlations are produced for the included symptom and HRQOL scores.
ETHICAL CONSIDERATIONS According to Danish legislation, surveys are exempt from ethical board review. However, a formal enquiry was made and the ethical board determined that the project was approved without further application to the ethical committee. Participants will be informed that study participation is voluntary, and will have no effect on their treatment and management. There are no risks associated with participating in the study.
All questionnaires and tests used in the study are validated, recommended and widely distributed clinically for diagnosing in psychiatry.
To facilitate a high proportion of completion, all participants (patients and controls) who complete the test are honored with Danish kroner (DDK) 150.
ANONYMITY The project is approved by the Data Protection Agency, File no. 17/3218. The data will be stored in a data sheet, REDCap.
FINANCE The study is a 100 % non-commercial study. The Jascha Fund has supported the post doc salary for 18 months. There will be applied for licenses, participation fees, and operating expenses.
DISSEMINATION AND TENTATIVE PUBLICATIONS
The study findings, both positive and negative results, will be disseminated through communication at congresses and written scientific publications. Publications will be made according to the Vancouver criteria with the tentative titles:
- Health-related quality of life in anorexia nervosa: Validation of a Danish language version in young and adult patients.
- In-patients treatment of anorexia nervosa: Does it improve health related quality of life?
- Patients with anorexia nervosa, not seeking established treatment: specific health related quality of life.
- Gender differences in health-related quality of life in patients with anorexia nervosa.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Anorexia nervosa | – | Other: Treatment settings as usual.Treatment settings as usual. |
| Healthy controls | – | –No interventions. |
Who may qualify
- Ages
- 13 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- PATIENTS will be recruited through specialized centres in Denmark and through contact to Patient Association's network. CONTROLS will be identified through public call for proposals. The proposals will be posted at institutions of further education and public schools in Odense with students in the appropriate age range.
Key inclusion criteria (1 listed)
- 1. Patients fulfilling Diagnostic and Statistical Manual of Mental Disorders, version 5 (DSM-5) criteria for anorexia nervosa.
Key exclusion criteria (2 listed)
- Patients and controls who are unable to complete a Danish language questionnaire.
- Controls: Any medication, except vitamins or oral contraceptives.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Treatment settings as usual.Treatment according to guidelines and the local instructions (psychotherapy and dietary guidance). | Other | Anorexia nervosa |
Primary outcome
EDQLS
Time frame: through a hospitalization, an average of 5 weeks
Disease specific health related quality of life
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Feb 2024.
- Background: PubMed 27923148Winkler LA, Frolich JS, Gudex C, Horder K, Bilenberg N, Stoving RK. Patient- and clinician- reported outcome in eating disorders. Psychiatry Res. 2017 Jan;247:230-235. doi: 10.1016/j.psychres.2016.11.047. Epub 2016 Nov 30.
- Background: PubMed 24857566Winkler LA, Christiansen E, Lichtenstein MB, Hansen NB, Bilenberg N, Stoving RK. Quality of life in eating disorders: a meta-analysis. Psychiatry Res. 2014 Sep 30;219(1):1-9. doi: 10.1016/j.psychres.2014.05.002. Epub 2014 May 14.
- Background: PubMed 26391650Winkler LA, Bilenberg N, Horder K, Stoving RK. Does specialization of treatment influence mortality in eating disorders?--A comparison of two retrospective cohorts. Psychiatry Res. 2015 Dec 15;230(2):165-71. doi: 10.1016/j.psychres.2015.08.032. Epub 2015 Aug 28.
- Background: PubMed 17470290Adair CE, Marcoux GC, Cram BS, Ewashen CJ, Chafe J, Cassin SE, Pinzon J, Gusella JL, Geller J, Scattolon Y, Fergusson P, Styles L, Brown KE. Development and multi-site validation of a new condition-specific quality of life measure for eating disorders. Health Qual Life Outcomes. 2007 Apr 30;5:23. doi: 10.1186/1477-7525-5-23.
- Background: PubMed 20701776Adair CE, Marcoux GC, Bischoff TF, Cram BS, Ewashen CJ, Pinzon J, Gusella JL, Geller J, Scattolon Y, Fergusson P, Styles L, Brown KE. Responsiveness of the Eating Disorders Quality of Life Scale (EDQLS) in a longitudinal multi-site sample. Health Qual Life Outcomes. 2010 Aug 11;8:83. doi: 10.1186/1477-7525-8-83.
- Background: PubMed 31069077Winkler LA, Hemmingsen SD, Gudex C, Blegvad AC, Stoving RK, Arnfred SMH. A Danish translation of the eating disorder quality of life scale (EDQLS). J Eat Disord. 2019 May 1;7:11. doi: 10.1186/s40337-019-0241-7. eCollection 2019.
- Individual participant dataSharing planned: Undecided. Data will be stored at Odense patient Data Explorative Network (OPEN).
Related trials for Anorexia Nervosa
Not yet recruiting
Be Body Brave: Digital Written Exposure Therapy for Eating Disorders
Eating Disorders
RecruitingObservational study
Speech Groups for Children Living With a Sibling Who Suffers From Anorexia Nervosa
Anorexia Nervosa
Enrolling by invitation
Sleep and Activity For Eating Disorders
Eating Disorders, Anorexia Nervosa
Not yet recruitingObservational study
Biomarkers in EV Associated With Marrow Adiposity in Anorexia
Anorexia Nervosa Restricting Type, Anorexia Nervosa (DSM-IV Revised Criteria)
Active, not recruiting
Targeting Social Function in Anxiety and Eating Disorders
Eating Disorders, Anorexia Nervosa
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
René K Støving, PhD principal investigator
Center for Eating Disorders, Odense University Hospital, & Psychiatric survived in Southern Denmark
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Anorexia Nervosa and Health-Related Quality Of Life, run by René Klinkby Støving at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
EDQLS (time frame: through a hospitalization, an average of 5 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03230435, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2024.